RxNorm Concept ID 602393

abacavir sulfate 600 MG / lamiVUDine 300 MG Oral Tablet

Semantic Concepts

RxNorm semantic concepts for the RxCUI 602393 unique identifier include: abacavir sulfate 600 MG / lamiVUDine 300 MG Oral Tablet (6363799), abacavir 600 MG / 3TC 300 MG Oral Tablet (3852277), abacavir (as abacavir sulfate) 600 MG / lamivudine 300 MG Oral Tablet (11443561), abacavir 600 MG / lamiVUDine 300 MG Oral Tablet (3727319), abacavir (as abacavir sulfate) 600 MG / lamiVUDine 300 MG Oral Tablet (11444226), abacavir 600 MG / lamivudine 300 MG Oral Tablet (12328796), Abacavir (as abacavir sulfate) 600 mg and lamivudine 300 mg oral tablet (11434950) and Product containing precisely abacavir (as abacavir sulfate) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) (11439085).

RxNorm Atom ID: 6363799 - Prescribable Name

abacavir sulfate 600 MG / lamiVUDine 300 MG Oral Tablet

Field NameField ValueField Description
RXCUI602393RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI6363799Unique identifier for the atom (RxNorm Atom ID)
Concept Descriptionabacavir sulfate 600 MG / lamiVUDine 300 MG Oral TabletDescription of concept identifier
Term Type (TTY)PSNTerm type in source with name and description
Term Type NamePrescribable NameName of term type in source
Term Type DescriptionSynonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.Description of term type in source
CODE602393"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Is Prescribable?YESThis drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF4096Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceRXNORMConcept source abbreviation
Source NameRxNorm VocabularyThe official name for a source
Source Version20AA_230103FThe source version
Source DateJanuary 03, 2023RxNorm data last updated
Source License ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source license contact information
Source Content ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source content contact information
Source Short NameRxNorm work done by the National Library of MedicineThe short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom ID: 3852277 - Synonym

abacavir 600 MG / 3TC 300 MG Oral Tablet

Field NameField ValueField Description
RXCUI602393RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI3852277Unique identifier for the atom (RxNorm Atom ID)
Concept Descriptionabacavir 600 MG / 3TC 300 MG Oral TabletDescription of concept identifier
Term Type (TTY)SYTerm type in source with name and description
Term Type NameSynonymName of term type in source
Term Type DescriptionSynonym of another TTY, given for clarity.Description of term type in source
CODE602393"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Is Prescribable?YESThis drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF4096Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceRXNORMConcept source abbreviation
Source NameRxNorm VocabularyThe official name for a source
Source Version20AA_230103FThe source version
Source DateJanuary 03, 2023RxNorm data last updated
Source License ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source license contact information
Source Content ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source content contact information
Source Short NameRxNorm work done by the National Library of MedicineThe short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom ID: 11443561 - Synonym

abacavir (as abacavir sulfate) 600 MG / lamivudine 300 MG Oral Tablet

Field NameField ValueField Description
RXCUI602393RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI11443561Unique identifier for the atom (RxNorm Atom ID)
Concept Descriptionabacavir (as abacavir sulfate) 600 MG / lamivudine 300 MG Oral TabletDescription of concept identifier
Term Type (TTY)SYTerm type in source with name and description
Term Type NameSynonymName of term type in source
Term Type DescriptionSynonym of another TTY, given for clarity.Description of term type in source
CODE602393"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Is Prescribable?YESThis drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF4096Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceRXNORMConcept source abbreviation
Source NameRxNorm VocabularyThe official name for a source
Source Version20AA_230103FThe source version
Source DateJanuary 03, 2023RxNorm data last updated
Source License ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source license contact information
Source Content ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source content contact information
Source Short NameRxNorm work done by the National Library of MedicineThe short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom ID: 3727319 - Tall Man Lettering Synonym

abacavir 600 MG / lamiVUDine 300 MG Oral Tablet

Field NameField ValueField Description
RXCUI602393RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI3727319Unique identifier for the atom (RxNorm Atom ID)
Concept Descriptionabacavir 600 MG / lamiVUDine 300 MG Oral TabletDescription of concept identifier
Term Type (TTY)TMSYTerm type in source with name and description
Term Type NameTall Man Lettering SynonymName of term type in source
Term Type DescriptionTall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.Description of term type in source
CODE602393"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Is Prescribable?YESThis drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF4096Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceRXNORMConcept source abbreviation
Source NameRxNorm VocabularyThe official name for a source
Source Version20AA_230103FThe source version
Source DateJanuary 03, 2023RxNorm data last updated
Source License ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source license contact information
Source Content ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source content contact information
Source Short NameRxNorm work done by the National Library of MedicineThe short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom ID: 11444226 - Tall Man Lettering Synonym

abacavir (as abacavir sulfate) 600 MG / lamiVUDine 300 MG Oral Tablet

Field NameField ValueField Description
RXCUI602393RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI11444226Unique identifier for the atom (RxNorm Atom ID)
Concept Descriptionabacavir (as abacavir sulfate) 600 MG / lamiVUDine 300 MG Oral TabletDescription of concept identifier
Term Type (TTY)TMSYTerm type in source with name and description
Term Type NameTall Man Lettering SynonymName of term type in source
Term Type DescriptionTall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.Description of term type in source
CODE602393"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Is Prescribable?YESThis drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF4096Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceRXNORMConcept source abbreviation
Source NameRxNorm VocabularyThe official name for a source
Source Version20AA_230103FThe source version
Source DateJanuary 03, 2023RxNorm data last updated
Source License ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source license contact information
Source Content ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source content contact information
Source Short NameRxNorm work done by the National Library of MedicineThe short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom ID: 12328796 - Semantic Clinical Drug

abacavir 600 MG / lamivudine 300 MG Oral Tablet

Field NameField ValueField Description
RXCUI602393RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI12328796Unique identifier for the atom (RxNorm Atom ID)
Concept Descriptionabacavir 600 MG / lamivudine 300 MG Oral TabletDescription of concept identifier
Term Type (TTY)SCDTerm type in source with name and description
Term Type NameSemantic Clinical DrugName of term type in source
Term Type DescriptionIngredient + Strength + Dose FormDescription of term type in source
CODE602393"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Is Prescribable?YESThis drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF4096Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceRXNORMConcept source abbreviation
Source NameRxNorm VocabularyThe official name for a source
Source Version20AA_230103FThe source version
Source DateJanuary 03, 2023RxNorm data last updated
Source License ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source license contact information
Source Content ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source content contact information
Source Short NameRxNorm work done by the National Library of MedicineThe short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom 12328796 Attributes

PropertyValueExplanation
RXN AI{350655} 68244RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI{602392} 221052RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM{350655} 68244RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM{602392} 190521RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AVAILABLE STRENGTH600 MG / 300 MGAvailable drug strengths listed in the order of ingredients from the drug
RXN BOSS FROM{350655} AISource of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM{602392} AMSource of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN HUMAN DRUGUSDrug available for use in Humans
RXTERM FORMTabThe RxTerm dose form name for this drug

RxNorm Atom ID: 11434950 - Designated preferred name

Abacavir (as abacavir sulfate) 600 mg and lamivudine 300 mg oral tablet

Field NameField ValueField Description
RXCUI602393RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI11434950Unique identifier for the atom (RxNorm Atom ID)
Concept DescriptionAbacavir (as abacavir sulfate) 600 mg and lamivudine 300 mg oral tabletDescription of concept identifier
Term Type (TTY)PTTerm type in source with name and description
Term Type NameDesignated preferred nameName of term type in source
Term Type DescriptionDescription of term type in source
CODE783301004"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Is Prescribable?YESThis drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVFContent view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceSNOMEDCT_USConcept source abbreviation
Source NameUS Edition of SNOMED CTThe official name for a source
Source Version2022_07_31The source version
Source DateJanuary 03, 2023RxNorm data last updated
Source License ContactNational Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)

https://support.nlm.nih.gov/support/create-case/
The source license contact information
Source Content ContactNational Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library Of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)

https://support.nlm.nih.gov/support/create-case/
The source content contact information
Source Short NameUS Edition of SNOMED CTThe short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom ID: 11439085 - Full form of descriptor

Product containing precisely abacavir (as abacavir sulfate) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug)

Field NameField ValueField Description
RXCUI602393RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI11439085Unique identifier for the atom (RxNorm Atom ID)
Concept DescriptionProduct containing precisely abacavir (as abacavir sulfate) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug)Description of concept identifier
Term Type (TTY)FNTerm type in source with name and description
Term Type NameFull form of descriptorName of term type in source
Term Type DescriptionDescription of term type in source
CODE783301004"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Is Prescribable?YESThis drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVFContent view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceSNOMEDCT_USConcept source abbreviation
Source NameUS Edition of SNOMED CTThe official name for a source
Source Version2022_07_31The source version
Source DateJanuary 03, 2023RxNorm data last updated
Source License ContactNational Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)

https://support.nlm.nih.gov/support/create-case/
The source license contact information
Source Content ContactNational Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library Of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)

https://support.nlm.nih.gov/support/create-case/
The source content contact information
Source Short NameUS Edition of SNOMED CTThe short name of a source as used by the NLM Knowledge Source Server

* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Information for Patients

Abacavir

Abacavir is used along with other medications to treat human immunodeficiency virus (HIV) infection. Abacavir is in a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs). It works by decreasing the amount of HIV in the blood. Although abacavir does not cure HIV, it may decrease your chance of developing acquired immunodeficiency syndrome (AIDS) and HIV-related illnesses such as serious infections or cancer. Taking these medications along with practicing safer sex and making other lifestyle changes may decrease the risk of transmitting (spreading) the HIV virus to other people.
[Read More]
Lamivudine

Lamivudine (Epivir) is used along with other medications to treat human immunodeficiency virus (HIV) infection in adults and children 3 months of age and older. Lamivudine (Epivir-HBV) is used to treat hepatitis B infection. Lamivudine is in a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs). It works by decreasing the amount of HIV and hepatitis B in the blood. Although lamivudine does not cure HIV, it may decrease your chance of developing acquired immunodeficiency syndrome (AIDS) and HIV-related illnesses such as serious infections or cancer. Taking these medications along with practicing safer sex and making other lifestyle changes may decrease the risk of transmitting (spreading) the HIV or hepatitis B virus to other people.
[Read More]
HIV/AIDS Medicines

What is HIV/AIDS?

HIV stands for human immunodeficiency virus. It harms your immune system by destroying CD4 cells. These are a type of white blood cells that fight infection. The loss of these cells makes it hard for your body to fight off infections and certain HIV-related cancers.

Without treatment, HIV can gradually destroy the immune system and advance to AIDS. AIDS stands for acquired immunodeficiency syndrome. It is the final stage of infection with HIV. Not everyone with HIV develops AIDS.

What is antiretroviral therapy (ART)?

The treatment of HIV/AIDS with medicines is called antiretroviral therapy (ART). It is recommended for everyone who has HIV. The medicines do not cure HIV infection, but they do make it a manageable chronic condition. They also reduce the risk of spreading the virus to others.

How do HIV/AIDS medicines work?

HIV/AIDS medicines reduce the amount of HIV (viral load) in your body, which helps by

  • Giving your immune system a chance to recover. Even though there is still some HIV in your body, your immune system should be strong enough to fight off infections and certain HIV-related cancers.
  • Reducing the risk that you will spread HIV to others

What are the types of HIV/AIDS medicines?

There are several different types of HIV/AIDS medicines. Some work by blocking or changing enzymes that HIV needs to make copies of itself. This prevents HIV from copying itself, which reduces the amount of HIV in the body. Several medicines do this:

  • Nucleoside reverse transcriptase inhibitors (NRTIs) block an enzyme called reverse transcriptase
  • Non-nucleoside reverse transcriptase inhibitors (NNRTIs) bind to and later change reverse transcriptase
  • Integrase inhibitors block an enzyme called integrase
  • Protease inhibitors (PIs) block an enzyme called protease

Some HIV/AIDS medicines interfere with HIV's ability to infect CD4 immune system cells:

  • Fusion inhibitors block HIV from entering the cells
  • CCR5 antagonists and post-attachment inhibitors block different molecules on the CD4 cells. To infect a cell, HIV has to bind to two types of molecules on the cell's surface. Blocking either of these molecules prevents HIV from entering the cells.
  • Attachment inhibitors bind to a specific protein on the outer surface of HIV. This prevents HIV from entering the cell.

In some cases, people take more than one medicine:

  • Pharmacokinetic enhancers boost the effectiveness of certain HIV/AIDS medicines. A pharmacokinetic enhancer slows the breakdown of the other medicine. This allows that medicine to stay in the body longer at a higher concentration.
  • Multidrug combinations include a combination of two or more different HIV/AIDS medicines

When do I need to start taking HIV/AIDS medicines?

It's important to start taking HIV/AIDS medicines as soon as possible after your diagnosis, especially if you

  • Are pregnant
  • Have AIDS
  • Have certain HIV-related illnesses and infections
  • Have an early HIV infection (the first 6 months after infection with HIV)

What else do I need to know about taking HIV/AIDS medicines?

It's important to take your medicines every day, according to the instructions from your health care provider. If you miss doses or don't follow a regular schedule, your treatment may not work, and the HIV virus may become resistant to the medicines.

HIV medicines can cause side effects. Most of these side effects are manageable, but a few can be serious. Tell your health care provider about any side effects that you are having. Don't stop taking your medicine without first talking to your provider. He or she may give you tips on how to deal with the side effects. In some cases, your provider may decide to change your medicines.

What are HIV PrEP and PEP medicines?

HIV medicines are not just used for treatment. Some people take them to prevent HIV. PrEP (pre-exposure prophylaxis) is for people who don't already have HIV but are at very high risk of getting it. PEP (post-exposure prophylaxis) is for people who have possibly been exposed to HIV.

NIH: Office of AIDS Research


[Read More]

* Please review the disclaimer below.